| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.
|
J Exp Med
|
2008
|
3.85
|
|
2
|
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
|
Clin J Am Soc Nephrol
|
2013
|
2.47
|
|
3
|
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.
|
Blood
|
2005
|
1.99
|
|
4
|
Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation.
|
Am J Transplant
|
2005
|
1.82
|
|
5
|
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.
|
Transplantation
|
2016
|
1.68
|
|
6
|
Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
|
J Clin Oncol
|
2013
|
1.50
|
|
7
|
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
|
Medicine (Baltimore)
|
2012
|
1.31
|
|
8
|
Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway.
|
J Allergy Clin Immunol
|
2006
|
1.22
|
|
9
|
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.
|
Transplantation
|
2003
|
1.13
|
|
10
|
Replacement kidney lipomatosis after renal transplantation.
|
Transplantation
|
2005
|
1.12
|
|
11
|
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
|
J Antimicrob Chemother
|
2010
|
1.10
|
|
12
|
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.
|
Clin Pharmacokinet
|
2004
|
1.05
|
|
13
|
Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology.
|
Drugs
|
2010
|
1.03
|
|
14
|
Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine.
|
Transplantation
|
2007
|
1.02
|
|
15
|
Correction of postkidney transplant anemia reduces progression of allograft nephropathy.
|
J Am Soc Nephrol
|
2011
|
1.02
|
|
16
|
TLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathway.
|
J Immunol
|
2007
|
1.01
|
|
17
|
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
|
Transpl Int
|
2008
|
1.01
|
|
18
|
Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy.
|
Clin Transplant
|
2003
|
1.01
|
|
19
|
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil.
|
Clin Pharmacokinet
|
2005
|
1.01
|
|
20
|
Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients.
|
Am J Transplant
|
2007
|
0.99
|
|
21
|
Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells.
|
PLoS One
|
2008
|
0.92
|
|
22
|
Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant.
|
Transplantation
|
2006
|
0.91
|
|
23
|
mTOR inhibition: the learning curve in kidney transplantation.
|
Transpl Int
|
2010
|
0.91
|
|
24
|
CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
|
Mol Immunol
|
2008
|
0.89
|
|
25
|
Follow-up after renal transplantation with organs from donors after cardiac death.
|
Transpl Int
|
2006
|
0.88
|
|
26
|
Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency.
|
Circ Cardiovasc Genet
|
2011
|
0.87
|
|
27
|
Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways.
|
Int Immunol
|
2005
|
0.86
|
|
28
|
TCF7L2 polymorphism associates with new-onset diabetes after transplantation.
|
J Am Soc Nephrol
|
2009
|
0.86
|
|
29
|
Anti CD25 treatment of human dendritic cells modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4 T cells: a potential tolerogenic effect.
|
Int Immunopharmacol
|
2007
|
0.85
|
|
30
|
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity.
|
Drugs
|
2014
|
0.84
|
|
31
|
The Orai-1 and STIM-1 complex controls human dendritic cell maturation.
|
PLoS One
|
2013
|
0.82
|
|
32
|
Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation.
|
Transpl Int
|
2012
|
0.82
|
|
33
|
Acute septic arthritis after kidney transplantation due to Acremonium.
|
Nephrol Dial Transplant
|
2003
|
0.82
|
|
34
|
Conversion to mTOR-inhibitor-based immunosuppression: which patients and when?
|
Transplant Res
|
2013
|
0.82
|
|
35
|
Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial.
|
Transpl Immunol
|
2013
|
0.81
|
|
36
|
Association of donor TNFRSF6 (FAS) gene polymorphism with acute rejection in renal transplant patients: a case-control study.
|
Nephrol Dial Transplant
|
2004
|
0.80
|
|
37
|
Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.
|
Clin Pharmacol Ther
|
2005
|
0.80
|
|
38
|
Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells.
|
J Leukoc Biol
|
2008
|
0.80
|
|
39
|
Analysis of human CD4 T lymphocyte proliferation induced by porcine lymphoblastoid B cell lines.
|
Xenotransplantation
|
2003
|
0.80
|
|
40
|
Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation.
|
J Med Genet
|
2009
|
0.80
|
|
41
|
Effects of immunosuppressive drugs on dendritic cells and tolerance induction.
|
Transplantation
|
2003
|
0.79
|
|
42
|
Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.
|
Blood
|
2010
|
0.79
|
|
43
|
Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.
|
Transplantation
|
2008
|
0.79
|
|
44
|
[Incidence and management of anemia in renal transplantation: an observational-French study].
|
Nephrol Ther
|
2008
|
0.79
|
|
45
|
Mycophenolic acid differentially affects dendritic cell maturation induced by tumor necrosis factor-alpha and lipopolysaccharide through a different modulation of MAPK signaling.
|
Mol Immunol
|
2010
|
0.79
|
|
46
|
Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.
|
Ther Drug Monit
|
2009
|
0.78
|
|
47
|
Recipient age and mycophenolate mofetil as the main determinants of outcome after steroid withdrawal: analysis of long-term follow-up in renal transplantation.
|
Transplantation
|
2005
|
0.78
|
|
48
|
Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
|
Br J Clin Pharmacol
|
2005
|
0.78
|
|
49
|
Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies.
|
Nephrol Dial Transplant
|
2012
|
0.78
|
|
50
|
Revisiting the effects of CMV on long-term transplant outcome.
|
Curr Opin Organ Transplant
|
2010
|
0.78
|
|
51
|
Comparative effects of sirolimus and cyclosporin on conduit arteries endothelial function in kidney recipients.
|
Transpl Int
|
2010
|
0.78
|
|
52
|
Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.
|
Transpl Int
|
2013
|
0.78
|
|
53
|
The role of Thymoglobulin induction in kidney transplantation: an update.
|
Clin Transplant
|
2012
|
0.78
|
|
54
|
Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
|
Clin Transplant
|
2007
|
0.78
|
|
55
|
Kidney transplantation in an elite HIV controller: limited impact of immunosuppressive therapy on viro-immunological status.
|
J Infect
|
2012
|
0.77
|
|
56
|
FasL-transfected endothelial cells decrease the proliferative response of allogeneic PBL.
|
Transpl Immunol
|
2002
|
0.77
|
|
57
|
Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant.
|
Clin Transplant
|
2007
|
0.77
|
|
58
|
Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantation.
|
Transplantation
|
2011
|
0.77
|
|
59
|
Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor.
|
Nephrol Dial Transplant
|
2011
|
0.77
|
|
60
|
Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.
|
Eur J Clin Pharmacol
|
2002
|
0.76
|
|
61
|
[Therapeutic monoclonal antibodies: update on the risk of opportunistic infections].
|
Med Sci (Paris)
|
2009
|
0.76
|
|
62
|
Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch.
|
Hum Immunol
|
2013
|
0.76
|
|
63
|
Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation.
|
Transpl Int
|
2010
|
0.76
|
|
64
|
Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgammaRIIIa genetic polymorphism.
|
Br J Clin Pharmacol
|
2007
|
0.75
|
|
65
|
Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.
|
Transplantation
|
2011
|
0.75
|
|
66
|
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients.
|
Pharmacogenet Genomics
|
2014
|
0.75
|
|
67
|
[Orientation of the immune response of the epithelium: epithelial cells, dendritic cells and lymphocytes].
|
Bull Acad Natl Med
|
2014
|
0.75
|
|
68
|
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.
|
J Clin Immunol
|
2019
|
0.75
|
|
69
|
Mycophenolic acid-treated dendritic cells generate regulatory CD4+ T cells that suppress CD8+ T cells' allocytotoxicity.
|
Int Immunol
|
2013
|
0.75
|
|
70
|
New insights into renal transplantation.
|
Curr Opin Organ Transplant
|
2010
|
0.75
|
|
71
|
Living with a functioning kidney transplant at 74 yr or older: a national epidemiological study.
|
Clin Transplant
|
2004
|
0.75
|
|
72
|
[Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up].
|
Nephrol Ther
|
2007
|
0.75
|
|
73
|
The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.
|
Eur J Health Econ
|
2005
|
0.75
|
|
74
|
Progression of pulse pressure in kidney recipients durably exposed to CsA is a risk factor for epithelial phenotypic changes: an ancillary study of the CONCEPT trial.
|
Transpl Int
|
2014
|
0.75
|
|
75
|
Hydatid cyst disease in a renal allograft recipient.
|
Saudi J Kidney Dis Transpl
|
2009
|
0.75
|
|
76
|
Kidney transplant with multiple renal artery grafts from deceased donors: are long-term graft and patient survival compromised?
|
Prog Transplant
|
2012
|
0.75
|